Rx-360 Endorses FDA's Secure Supply Chain Pilot Program
WASHINGTON, D.C., September 3, 2013 — On 20 August 2013, the FDA announced the initiation of a pilot import program. The Secure Supply Chain Pilot Program will launch in 2014 and, pending the outcome, may become permanent. Rx-360 commends FDA for establishing this important pilot program and recognizes that this initiative, if implemented, will bring benefits to patients, industry and FDA. Brian Johnson, Rx-360 Chair and Senior Director, Pfizer Supply Chain Security, noted that "as imports into the U.S. continue to grow, the burden on FDA resources increase. The pilot is a great example of FDA's strategy to leverage risk-based tools to help the agency focus its resources. Everyone wins if this pilot proves successful and a permanent program is ultimately implemented."
Rx-360 was formed in 2009 to support an industry-wide commitment to ensuring patient safety by enhancing quality and authenticity throughout the supply chain. The mission of the organization is timely in light of growing attacks and threats to an increasingly complex and global supply chain. Millions of people around the world are treated every day with the vital medicines that pharmaceutical and biotechnology companies provide. Management of the pharmaceutical supply chain has become one of the top public health concerns with respect to consumer safety. The globalization of distribution for both drug components and finished products has introduced many complications that Rx-360 is positioned to help resolve. To learn more about Rx-360, go to the website at www.Rx-360.org.
Please share this e-mail with your colleagues. If you are not a registered user on the Rx-360 web site, register for the website for free at www.Rx-360.org
Rx-360 | An International Supply Chain Organization - Washington D.C.
E-Mail: [email protected]